ID   PaCaDD-165
AC   CVCL_M467
SY   PACADD-165; PACADD165
DR   cancercelllines; CVCL_M467
DR   Cell_Model_Passport; SIDM01328
DR   DepMap; ACH-001380
DR   DSMZ; ACC-750
DR   DSMZCellDive; ACC-750
DR   Wikidata; Q54937427
RX   CelloPub=CLPUB00002;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Doubling time: 26.2 hours (CelloPub=CLPUB00002); ~35-45 hours (DSMZ=ACC-750).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Phe113Ser (c.338T>C); ClinVar=VCV000823709; Zygosity=Unspecified (DepMap).
CC   Omics: Deep exome analysis.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): DepMap; DSMZ
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 16.3 (DSMZ)
ST   D18S51: 17 (DepMap)
ST   D19S433: 12,14
ST   D21S11: 27
ST   D2S1338: 17,21
ST   D3S1358: 15
ST   D5S818: 10,12
ST   D7S820: 10
ST   D8S1179: 13
ST   FGA: 22,24
ST   Penta D: 13
ST   Penta E: 5,12
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 17
//
RX   CelloPub=CLPUB00002;
RA   Ruckert F., Werner K., Aust D., Hering S., Saeger H.-D.,
RA   Grutzmann R., Pilarsky C.;
RT   "Establishment and characterization of six primary pancreatic cancer
RT   cell lines.";
RL   Austin J. Cancer Clin. Res. 2:1055.01-1055.05(2015).
//